Table 2. Univariate and multivariate analysis of prognostic factors of OS.
Factors | Univariate analysis | Multivariate analysis | |||
HR (95 % CI) | P value | HR (95 % CI) | P value | ||
UBE2M (high vs. low) | 1.871(1.020-3.433) | 0.043 | 2.276(1.218-4.254) | 0.010 | |
TNM (III–IV vs. I–II) | 4.461(2.347-8.478) | <0.001 | 2.966(1.409-6.243) | 0.004 | |
AFP (ng/mL) (>20 vs.≤20) | 3.402(1.514-7.646) | 0.003 | 3.309(1.313-7.034) | 0.009 | |
Tumor size (cm) (>5 vs.≤5) | 2.286(1.260-4.147) | 0.007 | 1.397(0.713-2.739) | 0.330 | |
Tumor differentiation (III–IV vs. I–II) | 2.055(1.133-3.726) | 0.018 | 1.129(0.694-2.429) | 0.413 | |
Tumor number (multiple vs. solitary) | 1.194(0.645-2.211) | 0.572 | - | n.a. | |
Gender (male vs. female) | 0.697(0.358-1.357) | 0.288 | - | n.a. | |
Age, years (≥ 55 vs.< 55) | 0.828(0.451-1.519) | 0.542 | - | n.a. | |
HBsAg (positive vs. negative) | 1.023(0.492-2.130) | 0.951 | - | n.a. | |
Cirrhosis (positive vs. negative) | 1.029(0.611-2.394) | 0.585 | - | n.a. |
n.a., not applicable.